Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(3.00)
# 1,277
Out of 5,112 analysts
334
Total ratings
40.97%
Success rate
0.99%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $65 → $80 | $54.74 | +46.15% | 5 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $72 → $75 | $65.77 | +14.03% | 37 | Aug 6, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $50 → $65 | $77.08 | -15.67% | 5 | Jul 31, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $10.58 | +32.33% | 13 | Jul 25, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $7.91 | +1,164.22% | 13 | Jul 24, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $28.38 | +58.56% | 6 | Jul 23, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $21.42 | +250.14% | 39 | Jul 17, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $22.60 | +32.74% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $17.01 | +158.67% | 14 | Jul 1, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $21.14 | -52.70% | 14 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1 → $10 | $32.18 | -68.92% | 13 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $8.79 | +241.30% | 4 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $11.01 | +1,035.33% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $19.25 | -22.08% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.27 | +293.70% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $6.91 | -27.64% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $4.11 | +21.65% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $9.11 | +64.65% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $19.14 | +135.11% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $2.37 | +26.58% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $7.42 | +439.08% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.72 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.64 | +326.83% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $4.28 | -29.91% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.67 | +199.67% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.42 | +533.80% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $4.85 | +209.28% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4,520,000 → $68,930,000 | $1.74 | +3,961,494,152.87% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $5.91 | - | 4 | Jun 2, 2023 |
CRISPR Therapeutics AG
Aug 7, 2025
Maintains: Buy
Price Target: $65 → $80
Current: $54.74
Upside: +46.15%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $65.77
Upside: +14.03%
Ionis Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $77.08
Upside: -15.67%
Alumis
Jul 25, 2025
Reiterates: Buy
Price Target: $14
Current: $10.58
Upside: +32.33%
Korro Bio
Jul 24, 2025
Reiterates: Buy
Price Target: $100
Current: $7.91
Upside: +1,164.22%
Oruka Therapeutics
Jul 23, 2025
Reiterates: Buy
Price Target: $45
Current: $28.38
Upside: +58.56%
Legend Biotech
Jul 17, 2025
Reiterates: Buy
Price Target: $75
Current: $21.42
Upside: +250.14%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $22.60
Upside: +32.74%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $17.01
Upside: +158.67%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $21.14
Upside: -52.70%
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $32.18
Upside: -68.92%
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $8.79
Upside: +241.30%
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $11.01
Upside: +1,035.33%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $19.25
Upside: -22.08%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.27
Upside: +293.70%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $6.91
Upside: -27.64%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $4.11
Upside: +21.65%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $9.11
Upside: +64.65%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $19.14
Upside: +135.11%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $2.37
Upside: +26.58%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $7.42
Upside: +439.08%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.72
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.64
Upside: +326.83%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $4.28
Upside: -29.91%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.67
Upside: +199.67%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $1.42
Upside: +533.80%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $4.85
Upside: +209.28%
Sep 6, 2023
Maintains: Buy
Price Target: $4,520,000 → $68,930,000
Current: $1.74
Upside: +3,961,494,152.87%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $5.91
Upside: -